Given all the analyses and post-mortems of America’s pharmaceutical industry, it is impossible to avoid the notion that a “lack of innovation” has left the industry in its current, sorry state.
Whether this is true or simply a platitude remains to be seen; yet, the decimation of the industry caused by a decade of massive job cuts virtually guarantees that however little innovation we had in the past, there will certainly be less of it now.
